Eli Lilly has raised its ... Rocks stressed, however, that Lilly's primary production strategy is "self-run sites." He said: "We're quite comfortable building operating sites, and as the newest ...

Eli Lilly first broke ground on its state-of-the-art Concord manufacturing facility ... an official ribbon-cutting ceremony for its main building. Lilly plans to invest around $2 billion to ...

Charles R. Goulding and Aaron Rofe reveal how industry leaders like Eli Lilly, Johnson & Johnson, and Roche are going all-in ...

Recent clinical trial results Eli Lilly released suggest that it is building a lead in the weight loss space. Should investors buy the company's shares? Let's find out. In December, Eli Lilly ...

WestEnd Advisors LLC grew its position in Eli Lilly and Company by 210.0% in the first quarter. WestEnd Advisors LLC now owns 31 shares of the company’s stock valued at $26,000 after purchasing ...

Eli Lilly’s total deal value with Rznomics could exceed $1.3 billion, plus royalties. Rznomics will lead early-stage research; Lilly to handle development and sales. Get stock picks, daily ...

Eli Lilly recently announced leadership transitions, including new roles for Ilya Yuffa, Patrik Jonsson, and Kenneth Custer, marking a strategic shift aiming to expand its global market presence ...

Patents, economies of scale, and a powerful distribution network support Eli Lilly’s wide moat. Lilly’s patent-protected drugs carry strong pricing power, which enables the firm to generate ...

Deep-pocketed investors have adopted a bearish approach towards Eli Lilly LLY, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...